FDA Inspection 712920 — Baxalta Belgium Manufacturing SA

Baxalta Belgium Manufacturing SA — FEI 3002806503

The FDA completed an inspection of Baxalta Belgium Manufacturing SA on January 21, 2011 in Lessines. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 21, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Lessines (Belgium)